INCA Hospital do Câncer III

Rio de Janeiro, Rio de Janeiro 20220-410

0 studies enrolling now · 1 studies all time

What they study most

Soft Tissue Sarcoma

Studies at this site

• A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma — Completed